The Biopharma Pod podcast

Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech

0:00
5:10
Recuar 15 segundos
Avançar 15 segundos
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.

Mais episódios de "The Biopharma Pod"